Targeting tumours with novel radiopharmaceuticals
European Pharmaceutical Review
OCTOBER 19, 2023
One aspect that is extremely promising about radiopharmaceutical therapeutics is that they do not give a patient the side effects that are commonly experienced with chemotherapy. Hoppin served as lead director of Noria as the two organisations were sold to Bayer Healthcare in June of 2021.
Let's personalize your content